WASHINGTON (Reuters) - U.S. regulators are investigating potential risks from Abbott Laboratories Inc's HIV drug Kaletra, GlaxoSmithKline Plc's prostate drug Avodart and other medicines. The Food and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results